14d
MedPage Today on MSNBroadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ARTSAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown promising RIO trial results, indicating that immune-based therapies could ...
The presence of anti-CD4 autoantibodies in treatment-naive patients with advanced HIV was associated with a decreased rate of CD4 reconstitution following ART initiation.
--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions ... The 3D Epitope Mapping is a state-of-the-art solution that utilizes a combination of experimental ...
"We are enthusiastic to expand our toolbox for the discovery of novel therapeutic antibodies with a state-of-the-art mRNA immunization platform in this alliance," said Dr. Ilse Roodink, CSO of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results